Mechanism of action and clinical activity of tasquinimod in castrate-resistant prostate cancer
Neha Gupta, Omar Al Ustwani, Li Shen, Roberto Pili Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA Abstract: Castrate-resistant prostate cancer (CRPC) is a disease where survival is poor and treatment is challenging. Over the past 3 years, significant advances in the field...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2014-02-01
|
| Series: | OncoTargets and Therapy |
| Online Access: | http://www.dovepress.com/mechanism-of-action-and-clinical-activity-of-tasquinimod-in-castrate-r-a15784 |